Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Ocuphire Pharma

Youtube Subscribe

...

Ticker: OCUP

Sector: Biotechnology

Modern Optometrics Live kicks in today. Analyst Andrew Fein initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Buy rating and announces Price Target of $26. Analyst Andrew Feist: The need.
...
...
Extended Summary

Ocuphire Pharma

ocuphire pharma, inc. (OCUP) stock price, quote, news & analysis. The FDA recently approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of pharmacologically induced mydriasis. Modern Optometry Live kicks off today and we are happy to be invited back to present on Ocuphire Pharma. Modern Optometrics Live kicks in today. Leading diabetic macular edema companies are developing novel diabetic macual edema drugs that can be available in the diabetic macacular edema market in the coming years. Novartis, Roche, Kodiak Sciences, Adverum Biotechnologies, Graybug Vision, Oxurion, Ocuphire. Analyst Andrew Fein initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Buy rating and announces Price Target of $26. Analyst Andrew Feist: The need for an eyedrop treatment is highlighted by industry leader Allergan and several other companies developing pharmacological treatment options for presbyopia. Company is presenting at a conference tomorrow.

Related Results

...
March 13, 2024 15:46 (London Time)

Ocuphire Pharma

Ocuphire Pharma (OCUP) reported earnings of -$0.21 per share, missing the Zacks Consensus Estimate of -0.07 per share. The word on The Street in gen…
Sector: Biotechnology
Ticker: OCUP
Sentiment: 0.5859
MarketCap: 53,100,611.0
High: 2.17 Low: 2.13

Open: 2.13 Close: 2.15 Change: 0.02

Read more →
...
October 05, 2023 21:42 (London Time)

Ocuphire Pharma

Modern Optometrics Live kicks in today and we are happy to be invited back to present on Ocuphire Pharma. Leading diabetic macular edema companies a…
Sector: Biotechnology
Ticker: OCUP
Sentiment: 0.9022
MarketCap: 70,067,500.0
High: 3.47 Low: 3.24

Open: 3.26 Close: 3.45 Change: 0.19

Read more →
Search
Happening Now
Categories